DELPHI DIAGNOSTICS Trademark

Trademark Overview


On Wednesday, September 1, 2021, a trademark application was filed for DELPHI DIAGNOSTICS with the United States Patent and Trademark Office. The USPTO has given the DELPHI DIAGNOSTICS trademark a serial number of 97007644. The federal status of this trademark filing is REGISTERED as of Tuesday, September 19, 2023. This trademark is owned by Delphi Diagnostics, Inc.. The DELPHI DIAGNOSTICS trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical testing for diagnostic, prognosis and treatment purposes in the field of cancer research and disease classification; providing medical information to medical professionals in the field of cancer and disease classification; providing medical information to medical professionals on sensitivities of cancers to hormones and/or hormone therapies

Medical and scientific research in the field of cancer treatment and diagnosis; medical research services in the field of cancer; providing laboratory research services in the field of gene expression, namely, cancer biology; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; medical diagnosis and treatment of cancer; providing information about medical research in the field of cancer
delphi diagnostics

General Information


Serial Number97007644
Word MarkDELPHI DIAGNOSTICS
Filing DateWednesday, September 1, 2021
Status700 - REGISTERED
Status DateTuesday, September 19, 2023
Registration Number7170619
Registration DateTuesday, September 19, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 6, 2022

Trademark Statements


Goods and ServicesMedical testing for diagnostic, prognosis and treatment purposes in the field of cancer research and disease classification; providing medical information to medical professionals in the field of cancer and disease classification; providing medical information to medical professionals on sensitivities of cancers to hormones and/or hormone therapies
Disclaimer with Predetermined Text"DIAGNOSTICS"
Goods and ServicesMedical and scientific research in the field of cancer treatment and diagnosis; medical research services in the field of cancer; providing laboratory research services in the field of gene expression, namely, cancer biology; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; medical diagnosis and treatment of cancer; providing information about medical research in the field of cancer

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 14, 2021
Primary Code042
First Use Anywhere DateSaturday, July 31, 2021
First Use In Commerce DateSaturday, July 31, 2021

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 14, 2021
Primary Code044
First Use Anywhere DateSaturday, July 31, 2021
First Use In Commerce DateSaturday, July 31, 2021

Trademark Owner History


Party NameDelphi Diagnostics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Party NameDelphi Diagnostics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Party NameDelphi Diagnostics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Trademark Events


Event DateEvent Description
Sunday, February 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, February 11, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, February 11, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 19, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 19, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, August 15, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, August 14, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, August 9, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, July 27, 2023USE AMENDMENT FILED
Wednesday, August 9, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 27, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, May 30, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 30, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 30, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 31, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 6, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 6, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 1, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 26, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 26, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 25, 2022ASSIGNED TO LIE
Wednesday, September 14, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 2, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 2, 2022NON-FINAL ACTION E-MAILED
Friday, September 2, 2022NON-FINAL ACTION WRITTEN
Tuesday, August 23, 2022PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, August 16, 2022WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, August 2, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 20, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 20, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 20, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 4, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 4, 2022NON-FINAL ACTION E-MAILED
Wednesday, May 4, 2022NON-FINAL ACTION WRITTEN
Tuesday, May 3, 2022ASSIGNED TO EXAMINER
Thursday, October 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 4, 2021NEW APPLICATION ENTERED